MIM
BCAX

MetLife Investment Management’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

MetLife Investment Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,163
Closed -$158K – 2938
2025
Q1 		$158K Hold
12,163
– – ﹤0.01% 2314
2024
Q4 		$212K Buy
+12,163
New +$212K ﹤0.01% 2277